Abstract Adjuvant hormonal therapy is recommended for women with hormone receptor (HR)-positive breast cancer. Though critical, many patients are non-adherent to this therapy. Few scales have been developed to specifically address beliefs about adjuvant hormonal therapy. This study explores the clarity and relevance of the Beliefs about Medicine Questionnaire (BMQ) in the context of adherence behaviors to hormonal therapy in Black and White breast cancer survivors. We recruited women diagnosed with HR-positive cancer from the Washington, DC, area. An interviewer administered a standardized survey and conducted a cognitive interview. Participants rated the BMQ across three areas: relevance, difficulty, and clarity. We coded whether the comments identified item level issues: limited applicability, unclear reference, unclear perspective, or wording or tone. In-depth interviews were conducted with women who prematurely discontinued hormone therapy. The sample (n = 30) was equally split between Black and White survivors. On average, women were 57.9 years old (SD = 9.0). Overall 77% rated scale as relevant. Cognitive interviews revealed areas of perceived limited acceptability such as the notion of becoming too dependent or the notion of becoming worse if not taking the medication. Women who discontinued hormonal therapy (n = 2) felt ambivalent towards hormonal therapy as they reported having both positive and negative beliefs about the medication. Our study findings suggest new areas for further research and instrument development to accurately measure self-reported beliefs about hormonal therapy by HR-positive breast cancer survivors.
Introduction
Hormonal therapy has contributed to significant reductions in recurrence and mortality in breast cancer for women with hormone receptor (HR) positive breast cancer [1, 2] . However, studies show 30-50% of survivors fail to adhere to the treatment [2, 3] . Patients' beliefs about medications are important predictors of medication adherence [4] . Identifying medication beliefs measures that are relevant to adjuvant hormonal therapy is important since the characteristics of hormonal medication can differ from other medications. For instance, adjuvant hormonal therapy is taken when the signs of disease are no longer present but when side effects often persist. Additionally, the benefits of medication impact a future outcome: potential cancer recurrence.
Currently, there are no gold standard measures for assessing patients' beliefs about adjuvant hormonal therapy. Some authors have used Silliman's scale [5] to assess the survivor's risk/benefit perceptions when deciding to take hormonal therapy [6, 7] . To assess current beliefs about hormonal therapy, researchers have either developed items [8] or used validated scales such as the Beliefs about Medicine Questionnaire (BMQ) [9] in predominantly White samples. The BMQ is a well-validated measure developed with a sample of chronically ill patients, predominantly patients with diabetes, mental health problems, cardiac problems, and a smaller sample of cancer patients [4] . Grunfeld and colleagues [9] used the BMQ with a sample of breast cancer patients and found an association between the BMQ necessity subscale and hormonal therapy adherence. The study also included open-ended questions that queried for the perceived benefits of taking hormonal therapy. Interestingly, the beliefs that were most commonly reported (e.g., hormonal therapy will stop me from getting cancer, hormonal therapy will decrease the risk of developing breast cancer) are not captured by the BMQ items. Thus, it is important to examine breast cancer survivors' perceptions on the applicability of BMQ to hormonal medication. This study aims to explore the clarity and relevance of the BMQ in the relation to hormonal therapy in a racially diverse sample of Black and White breast cancer survivors. Findings from this study can provide insights for developing new measures to capture breast cancer survivors' specific beliefs about hormonal therapy.
Methods
Setting and Sample Participants were recruited via oncology clinics and community outreach in Washington, DC. Women were eligible if they had an HR positive breast cancer diagnosis and had completed primary therapy, had been prescribed hormonal therapy, self-identified as Black or White, were ≥21 years old, and spoke English. Not having the cognitive ability to provide consent was an exclusion criterion. Identified participants were first contacted by phone to confirm eligibility, obtain consent, and schedule a time for the interview. The interviews were completed on a second call. In-depth interviews were conducted with two women who reported discontinuing hormonal treatment prematurely. Participants received a $15 gift card by mail. Study procedures were approved by Georgetown University Institutional Review Board.
Measures
Demographic Information Demographic factors included age, income, marital status, education, and race.
Beliefs About Medicine The BMQ assesses general and specific beliefs about medicine using a cost-benefit framework in which beliefs about the necessity of taking the medication are weighted against the concerns. We used the ten-item subscale from the BMQ (BMQ-specific) that captures beliefs about a specific prescribed medication that can be adapted to any medication [4] . The BMQ includes two five-item subscales on a five-point Likert response option (ranging from strongly agree to strongly disagree): perceived necessity of medication and perceived concerns of taking the medication.
Scale Clarity and Relevance We used cognitive interviews [10] [11] [12] to query whether participants thought the scale was (1) relevant, (2) difficult to answer, (3) and clear (yes vs. no) and to comment on items if they found them to be problematic. We calculated the frequency for the binary responses for relevance, difficulty, and clarity for the scale (yes vs. no). We used the problem types classification suggested by Knafl [13] to categorize the open-ended responses that pertained to the scale or to specific items as follows: Limited Applicability, comments that suggest that the item is not applicable to certain situations; Unclear Reference, lack of clarity regarding the aspects that items address; Unclear Perspective, lack of clarity in the perspective from which an item should be answered; and Wording or Tone, words perceived to be confusing, offensive, or that prime a negative tone. Open-ended questions were included to understand adherence challenges for women who spontaneously reported discontinuing therapy. Responses were coded to capture the experiences taking medication and reasons for discontinuation.
Analysis
Descriptive statistics were computed for the demographic characteristics. We calculated the frequencies of the BMQ binary responses (whether the scale was considered to be relevant, difficult, and clear; yes vs. no) and conducted a content analysis of open-ended responses and in-depth interviews using Knafl and colleagues' problem types classification.
Results
Sample Characteristics and BMQ Reliability On average, women were 57.9 years old (SD = 9.0). Around half (43.3%) had an annual household income ≥ $60,000, and 60% had completed a college degree or more. Half self-identified as Black and half as Whites. Two women self-identified as Latina (one Black and one White). Black women were significantly less likely to be married (see Table 1 ).
Clarity and Relevance Most participants perceived the BMQ to be relevant (77%), not difficult to answer (83.3%), and clear (100%). There were no significant differences by race. However, some participants felt that some items were not applicable for hormonal therapy medication: Bsome questions are confusing. Seem more appropriate for allergy type meds,^Bseems like these may be for a different med like blood pressure.^Other items raised issues about unclear reference. The meaning of the word Bmystery^was unclear as well as the notion of Bbecoming worse.^Other comments suggested a problem of unclear perspective. For instance, questions related to the future or to hypothetical situations were harder to answer and they felt their answers were speculative. In relation to wording and tone, the notion of Bbecoming worse^was challenged by some participants since they did not feel they were currently sick (see Table 2 ).
Two of the White survivors spontaneously reported that they had discontinued their medication, for 8 and 3 months respectively, but both were open to reconsidering that decision. When probed regarding their reasons for early discontinuation, both pointed to the side effects and impact on quality of life as main reasons for stopping treatment. They expressed ambivalence in knowing that the hormonal therapy could increase survival but also having trouble dealing with the side effects and how they impacted their everyday life.
Discussion
To our knowledge, this was the first descriptive study to examine the clarity and relevance of BMQ in the context of hormonal therapy adherence in breast cancer survivors. Participants noted some instances of perceived limited applicability (e.g., seemed to be developed for other medications), unclear reference (medicines protective from becoming worse), unclear perspective (uncertainty about hypothetical and future-oriented questions), and wording/tone (the word Bworse^assuming they were currently sick) that deserve further exploration.
Prior studies have found that high scores on BMQ necessity are associated with medication adherence while high scores on concerns are related to non-adherence [4] . Table 2 Problem types and quotes in BMQ items
BMQ items Problem types Quotes
Perceived Necessity Subscale My current health depends on hormonal therapy medications Limited applicability Bit is more long termM y life would be very hard without hormonal therapy medication Unclear perspective Bvery speculativeŴ ithout hormonal therapy medications, I would become very ill Unclear reference Bsome people get extremely ill, define extremely illM y health in the future will depend on hormonal therapy medications Unclear perspective BI had to really give them some thought. I was not sure about future questions, can only go on the nowĤ ormonal therapy medications will protect me from becoming worse
Unclear reference Wording or tone
Bwhat is worse^? Bthe meaning of becoming worse is not clear, worse than now, worse than when I had the treatment?^Bbecoming worse could be betterB don't like the becoming worse, it assumes you are currently sick,^BI don't have strong feeling about my meds, I feel that the cancer is gone, the meds help ensure that the cancer won't come back.P Likewise, the BMQ necessity-concerns differential (i.e., positive score-benefits outweigh costs and vice versa) has also been associated with adherence [4] . However, this scoring may fail to identify a subset of patients like the participants who discontinued in our study who understood the necessity of taking hormonal therapy but also raised several concerns at the same time. The ambivalent perception of hormonal treatment has also been described [14] in a qualitative study with breast cancer survivors. Identifying patients who score high on both necessities and concerns (ambivalent patients) would be important, since the association between beliefs and intentions/behavior is weaker in individuals who are ambivalent [15] and there are unique intervention strategies (e.g., motivational interviewing) that may be more effective to enhance adherence for this subgroup. Thus, designing surveys that capture relevant beliefs (uncertainty about recurrence) and ambivalent attitudes is warranted. The study had certain limitations. The sample was a small convenience sample of women with a high level of education, so the generalizability of the results is limited. Two participants spontaneously reported that they had discontinued treatment, but we did not explicitly ask about discontinuation. Thus, we cannot know how many women had actually stopped taking the medication. We did not find race differences, but future larger studies should examine whether race and other socio-demographic factors impact the perceptions of relevance and clarity of the BMQ. Future studies should also explore further survivor's experiences taking hormonal therapy to develop specific measures to assess beliefs about hormonal therapy in HR positive breast cancer survivors.
